Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.17690567 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- SGLT-2 inhibitors demonstrate better cardiovascular and renal outcomes compared to DPP-4 inhibitors in treating type 2 diabetes, with potential additional benefits in weight and blood pressure control.